Market Overview

I think you’ll love what you hear,
what you’ll see and the opportunities
that will be set before you.
- Jon Najarian
GET TICKETS

Mid-Afternoon Market Update: Dow Falls 600 Points; Solaredge Technologies Shares Surge Following Strong Q1 Results

Share:

Toward the end of trading Tuesday, the Dow traded down 2.28 percent to 25,836.34 while the NASDAQ declined 2.55 percent to 7,916.33. The S&P also fell, dropping 2.14 percent to 2,869.67.

Leading and Lagging Sectors

Tuesday afternoon, the utilities shares slipped by just 0.3 percent. Meanwhile, top gainers in the sector included Ormat Technologies, Inc. (NYSE: ORA) up 4 percent, and Genie Energy Ltd (NYSE: GNE) up 4 percent.

In trading on Tuesday, information technology shares fell 2.5 percent.

Top Headline

TransDigm Group Incorporated (NYSE: TDG) reported better-than-expected earnings for its second quarter and raised its FY19 guidance.

Earnings came in at $4.21 per share, beating estimates of $3.80 per share. Sales came in at $1.196 billion, beating estimates of $1.13 billion.

Transdigm Group raised its FY2019 EPS guidance from $16.42-17.1 to $16.47-17.15. The company also raised its FY2019 sales guidance from $4.145 billion-4.235 billion to $5.395 billion-5.485 billion.

 

Equities Trading UP

Itron, Inc. (NASDAQ: ITRI) shares got a boost, shooting up 20 percent to $64.28 after the company reported better-than-expected Q1 EPS and sales. Baird also upgraded the stock from Neutral to Outperform.

Shares of Solaredge Technologies Inc (NASDAQ: SEDG) shot up 22 percent to $53.32 after the company reported higher-than-expected Q1 EPS and sales results. The company also issued Q2 sales guidance.

Cohu, Inc. (NASDAQ: COHU) shares were also up, gaining 22 percent to $18.91 after the company reported better-than-expected Q1 sales and the stock was upgraded by Stifel Nicolaus from Hold to Buy.

Equities Trading DOWN

Catalyst Pharmaceuticals Inc (NASDAQ: CPRX) shares dropped 40 percent to $3.70 after the FDA approved the company's competitor to its Firdapse drug.

Shares of Intersect ENT Inc (NASDAQ: XENT) were down 24 percent to $25.28 after SVB Leerink downgraded the stock from Outperform to Market Perform and lowered the price target from $41 to $29 following the company report of worse-than-expected Q1 EPS. The company also cut FY19 sales guidance.

Nautilus, Inc. (NYSE: NLS) was down, falling around 20 percent to $4.24 after the company reported worse-than-expected Q1 EPS and sales results.

Commodities

In commodity news, oil traded down 1.5 percent to $61.34 while gold traded up 0.1 percent to $1,285.10.

Silver traded down 0.2 percent Tuesday to $ 14.905, while copper fell 1.7 percent to $2.781.

 

Eurozone

European shares closed lower today. The eurozone’s STOXX 600 fell 1.37 percent, the Spanish Ibex Index fell 1.03 percent, while Italy’s FTSE MIB Index dropped 0.89 percent. Meanwhile the German DAX dropped 1.58 percent, and the French CAC 40 declined 1.6 percent while U.K. shares fell 1.63 percent.

Economics

The Johnson Redbook Retail Sales Index rose 1.3 percent during the first four weeks of April versus March.

U.S. job openings rose to 7.5 million in March, versus prior reading of 7.1 million, according to the Labor Department's JOLTS report.

Data on consumer credit for March will be released at 3:00 p.m. ET.

Posted-In: Mid-Afternoon Market UpdateNews Eurozone Commodities Global Intraday Update Markets

 

Related Articles (COHU + CPRX)

View Comments and Join the Discussion!
Lightning Fast
Market News Service
$199 Free 14 Day Trial

Opinion | The Risks Facing Uber Ahead Of Its IPO

Lamb Weston's Growth Is Underappreciated, BofA Says In Upgrade